DLI is an innovative in vitro diagnostic company commercializing fully automated random-access LC-MS/MS systems, that generate accurate and precise testing results in minutes close to the point of patient care, for the best medical outcomes and services. Our mission is to enable clinicians to make diagnosis and treatment decisions with prompt testing results during patient’s first visit, instead after waiting for days or weeks.